The prevalence of the metabolic syndrome has increased in tandem with that of obesity. The metabolic syndrome is associated with structural and functional cerebral damage. A new study confirms the association between the metabolic syndrome and reduced brain volume in the absence of diabetes mellitus. Here, we highlight how vascular dysfunction potentially contributes to this brain damage. The prevalence of obesity among US adults is currently an astonishing 35.9%, with 15.5% of the population having a BMI ≥35 kg/m 2 and 6.3% having a BMI ≥40 kg/m 2 . 1 Obes ity is strongly linked to the metabolic s yndrome-a cluster of disease risk factors that includes hypertension, abdominal obesity, elevated triglyceride levels, low HDL cholesterol levels and hyperglycaemia (or marked insulin resistance).
The prevalence of obesity among US adults is currently an astonishing 35.9%, with 15.5% of the population having a BMI ≥35 kg/m 2 and 6.3% having a BMI ≥40 kg/m 2 . 1 Obes ity is strongly linked to the metabolic s yndrome-a cluster of disease risk factors that includes hypertension, abdominal obesity, elevated triglyceride levels, low HDL cholesterol levels and hyperglycaemia (or marked insulin resistance). 2 The preva lence of the metabolic syndrome increases with increasing weight and age, reaching nearly 40% in 40-60 year olds and more than 50% in those over 60 years of age. 3 What is particularly worrisome, in addition to the increased rates of diabetes mellitus and cardio vascular disease that are associated with the metabolic syndrome, is the fact that the metabolic syndrome is also associated with substantial brain impairment. Tiehuis and colleagues studied a large cohort of m iddleaged and elderly patients with mani fest arterial disease, including coronary artery disease (myocardial infarction and/ or coronary bypass/angioplasty), cerebro vascular disease (transient ischa emic attack or stroke), peripheral arterial disease (claudi cation, atrest pain or angioplasty) and aortic aneurism (distal aortic diameter ≥3 cm). 4 The researchers demonstrated that presence of the metabolic syndrome is associated with global brain atrophy, even in individu als without diabetes mellitus. 4 Although this finding is interesting, caution should be taken when trying to generalize these data on the effects of the metabolic syndrome on brain integrity to other individuals with the metabolic syndrome who have milder forms of arterial disease.
Autopsy studies have shown that brain atrophy is part of the normal ageing pro cess. 5 These studies show that brain mass peaks at 20 years of age, after which time it declines at a rate of 0.1-0.2% per year, with the rate of brain tissue loss accelerating after about 65 years of age. 5 Postmortem analysis of the brains of participants in the HonoluluAsia Ageing Study (HAAS) provided early evidence of a direct relationship between high blood pressure and the following fac tors: brain atrophy; increased neuropathic cerebro vascular lesions; and develop ment of neurofibrillary tangles and neuritic plaques. 6 MRI is now extensively used to non invasively characterize brain volume; MRI studies have established that brain atrophy is a feature of normal ageing and have confirmed that atrophy rates increase with a large number of comorbidities.
Tiehuis and coworkers provide evidence that the metabolic syndrome is associ ated with reduced brain volume. 4 Previous crosssectional studies have reported associ ations between the metabolic syndrome and silent brain infarctions, white matter lesions and, among other things, elevated levels of myoinositol that are suggestive of neuro inflammation. 7 Further more, the metabolic syndrome has been associated with marked cognitive dysfunction. Memory, attention and executive functions are the most com monly reported cognitive domains affected. However, most of these cog nitive and struc tural brain findings, inclu ding those of the SMART-MR study reported by Tiehuis and colleagues, 4 have been derived from studies of middleaged or elderly individu als. As a consequence, it is difficult to ascer tain the effects of the metabolic syndrome on the brain that are independent of cardio vascular disease, which so often accompanies the metabolic syndrome in this age group.
Focusing on much younger patients might provide a clearer view of the effect of the metabolic syndrome on the brain. Although not completely free of incipient cardio vascular pathology, such as increased carotid stiffness and increased intima-media thick ness, adolescents with obesity and the metabolic syndrome are devoid of substan tial occlusive vascular disease. There fore, adolescents might be a useful population to ascertain how the metabolic syndrome, inde pendent of manifest vascular disease, affects brain integrity.
Previously, we demonstrated in adoles cents that the metabolic syndrome, and insulin resistance in particular, was associ ated with increased brain atrophy and reduc tions in hippocampal volumes; impor tantly, these associations remained significant even after adjusting for BMI. 8 Further more, we demonstrated that adolescents with obesity and the metabolic syndrome also had cognitive deficits and reductions in white matter microstructural integrity, in con trast to adolescents matched by educa tion level, socioeconomic status and other demographic variables but without the metabolic syndrome. 8 Insulin resistance is key to the metabolic syndrome and drives the ill effects of obesity on the brain, likely due to the associated endothelial dysfunction and abnormali ties in peripheral vascular reactivity. The brain uses glucose as its main metabolic energy source and the glucose transporter type 1 (GLUT1), at the blood-brain barrier becomes saturated at normal physio logical levels of blood glucose (Figure 1 ). When the brain becomes activated and utilizes increased amounts of metabolic substrate, the main way to shuttle extra glucose across the blood-brain barrier at these times of high regional demand is to relax the regional capillary bed (capillary recruit ment), thus exposing new glucose transport ers to the blood. These additional glucose transporters help shuttle more glucose to the activated region of the brain. We have hypothesized that the diminished cerebral tissue perfusion and vascular reactivity associated with insulin resistance are at least partly responsible for the detrimental effects of insulin resistance and the metabolic syn drome on brain integrity. Brain perfusion and cerebral vascular reactivity are essen tial for maintaining energydependent processes (such as regional brain activa tion) by, in addition to generating sufficient metabolic substrate, also clearing the 'waste products' produced by neuronal activity (for example, CO 2 , excess lactate, other metabolites and heat). 9 Consequently, we have proposed that individuals with insulin resistance and/or the metabolic syndrome are unable to maintain an optimal neuronal environment, particularly during periods of high cerebral demand such as during regional brain activation. We contend that this dysfunction, when coupled with other detri mental factors that are associated with obesityrelated metabolic syndrome (such as inflammation, dysregulation of the h ypothalamic-pituitary axis, reduced pro tective neurotrophin levels and increased oxidative stress) will damage the brain. 7, 10 Going forward, careful investigation of the role of endothelial function and cerebral vas cular reactivity is warranted to understand the adverse effects of obesityassociated met abolic syndrome on brain integrity. Although the results presented by Tiehuis and col leagues are interesting, further prospective longitudinal studies of young individuals at high risk are required to help unravel the mechanisms involved in these processes. Figure 1 | Glucose metabolism in the brain. Glucose is transported from the blood to the brain via GLUT1. Regional activation of the brain leads to local reductions in interstitial glucose levels, which are compensated via capillary recruitment leading to increased capillary density. Abbreviation: GLUT1, glucose transporter type 1.
